John B. Payne - 16 Dec 2022 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
President and CEO, Director
Signature
/s/ John B. Payne
Issuer symbol
ZIVO
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
20 Dec 2022, 15:15:35 UTC
Previous filing
28 Jan 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +191,016 $0.000000 191,016 16 Dec 2022 Common Stock 191,016 $2.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vested immediately upon grant.